3d.FAB platform printing branched vessels with an extreme flexibility and …
… printed in Z-axis without additional support!
Printing For Life
More information about this 3D printer, now available at 3d.FAB, here.
For the 10 years of the ACDV (Association de la Chimie Du Végétal) celebrated on July 3rd in Paris, the 3d.FAB platform has produced 200 blue roosters, the French Fab symbol in biosourced polymer!
Collaboration between 3d.FAB and ESRF (Paul TAFFOREAU from European Synchrotron Radiation Facility).
A unique experience in the world!
You can follow the 250 hours printing directly live on the 3d.FAB YouTube channel!!!
Direct link here
Come meet us at Biosensors Conference this week!
https://www.elsevier.com/events/conferences/world-congress-on-biosensors/about
We are present at the SELECTBIO congress in Rotterdam!
https://selectbiosciences.com/conferences/agenda.aspx?pid=5712&conf=B3DPLSEU2018
The innovative platform 3D.FAB will be present at 2nd international conference on 3D printing technology and innovations, the 19th and 20th of March 2018 in London, UK. Dr. Laurent Gremillard (MATEIS Laboratory) will talk about “Robocasting of dense ceramic parts”, then Dr. Edwin-Joffrey Courtial (ICBMS) will talk about “Yield stress agent for silicone 3D printing” as part of FASSIL, a collaborative FUI project.
The Personalised Health Care Initiative is a large-scale scientific and technological proposal that will address the grand challenge of developing regenerative, precision and personalised medicine to improve the quality of life of billions of patients worldwide.
The proposal is coordinated by the University of Minho, and is supported by a Steering Committee of 15 members, including UCBL-3d.FAB representing academia and industry leaders from across Europe. It is also supported by a large number of organisations, including over 140 academia and health institutes, 40 research institutes, 95 industry and associations and 25 regional and national authorities.
Through a multi-actor and multi-disciplinary approach, the initiative will focus on the development of targeted and specific therapies for diseases that have an impact on society and the patient, the development of new technologies, and preventive and predictive tools.
FET Flagships are one of the most prestigious, highly-funded, strongest and game-changing instruments of EU research. They will involve a total budget of about €1 billion including EU and public and private funding.
For more information and to show your support, please visit the Personalised Health Care Initiative website here.